PL2501375T3 - Kompozycje przeciwdrobnoustrojowe zawierające wolne kwasy tłuszczowe - Google Patents
Kompozycje przeciwdrobnoustrojowe zawierające wolne kwasy tłuszczoweInfo
- Publication number
- PL2501375T3 PL2501375T3 PL10779550T PL10779550T PL2501375T3 PL 2501375 T3 PL2501375 T3 PL 2501375T3 PL 10779550 T PL10779550 T PL 10779550T PL 10779550 T PL10779550 T PL 10779550T PL 2501375 T3 PL2501375 T3 PL 2501375T3
- Authority
- PL
- Poland
- Prior art keywords
- fatty acids
- compositions containing
- free fatty
- containing free
- antimicrobial compositions
- Prior art date
Links
- 230000000845 anti-microbial effect Effects 0.000 title 1
- 235000021588 free fatty acids Nutrition 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Birds (AREA)
- Biophysics (AREA)
- Dispersion Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Biotechnology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IE20090872 | 2009-11-17 | ||
| EP10779550.2A EP2501375B1 (en) | 2009-11-17 | 2010-11-17 | Antimicrobial compositions containing free fatty acids |
| PCT/EP2010/067710 WO2011061237A1 (en) | 2009-11-17 | 2010-11-17 | Antimicrobial compositions containing free fatty acids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2501375T3 true PL2501375T3 (pl) | 2017-12-29 |
Family
ID=43412541
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL10779550T PL2501375T3 (pl) | 2009-11-17 | 2010-11-17 | Kompozycje przeciwdrobnoustrojowe zawierające wolne kwasy tłuszczowe |
Country Status (7)
| Country | Link |
|---|---|
| US (4) | US20120289591A1 (pl) |
| EP (1) | EP2501375B1 (pl) |
| CN (2) | CN102639129B (pl) |
| CA (1) | CA2781550C (pl) |
| ES (1) | ES2643862T3 (pl) |
| PL (1) | PL2501375T3 (pl) |
| WO (1) | WO2011061237A1 (pl) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5548121B2 (ja) | 2007-05-14 | 2014-07-16 | リサーチ ファウンデーション オブ ステイト ユニバーシティ オブ ニューヨーク | バイオフィルム中の細菌細胞における生理学的分散応答の誘導 |
| PL2501375T3 (pl) | 2009-11-17 | 2017-12-29 | Folan | Kompozycje przeciwdrobnoustrojowe zawierające wolne kwasy tłuszczowe |
| NL2009407C2 (en) * | 2012-09-03 | 2014-03-04 | Dutch Renewable Energy B V | Antimicrobial composition. |
| US10300176B2 (en) | 2013-11-25 | 2019-05-28 | Medline Industries, Inc. | Catheter lock solution formulations |
| WO2016051767A1 (en) * | 2014-09-30 | 2016-04-07 | The Kitasato Institute | Narrow-spectrum antibacterial antibiotics targeting specific types of bacteria that synthesizes menaquinone through an alternative pathway via futalosine or 6-aminodeoxyfutalosine as an intermediate. |
| CA2968320A1 (en) | 2014-11-19 | 2016-05-26 | Cassandra K JONES | Chemical mitigants in animal feed and feed ingredients |
| WO2016115639A1 (en) * | 2015-01-23 | 2016-07-28 | Biocidium Biopharmaceuticals Inc. | Anti-bacterial compositions |
| CN107530273B (zh) * | 2015-04-28 | 2021-07-09 | 库泰克有限责任公司 | 含有缬草提取物的组合物 |
| CN106551902B (zh) * | 2015-09-17 | 2020-07-03 | 阿赖耶识(上海)生物技术有限公司 | 一种高稳定的非囊泡型纳米颗粒及其在治疗微生物感染中的应用 |
| US9826912B2 (en) | 2015-11-11 | 2017-11-28 | Livassured B.V. | Photoplethysmographic device for measuring a heart rhythm |
| WO2017100580A1 (en) * | 2015-12-10 | 2017-06-15 | Aaron Seitz | Sphingolipid coatings and process for manufacturing sphingolipid coatings effective for inhibiting biofilm formation |
| CN106913563A (zh) * | 2016-01-04 | 2017-07-04 | 广东工业大学 | 多烯脂肪酸类化合物在制备抗耐药菌药物中的应用 |
| US11065223B2 (en) | 2016-02-22 | 2021-07-20 | Board Of Regents, The University Of Texas System | Antimicrobial compositions and uses thereof |
| JP7138702B2 (ja) * | 2017-09-22 | 2022-09-16 | ベクトン・ディキンソン・アンド・カンパニー | カテーテルロック溶液としての使用のための4%クエン酸三ナトリウム溶液 |
| US11406594B2 (en) | 2017-11-28 | 2022-08-09 | University Of Florida Research Foundation, Inc. | Oleogel compositions for retinal drug delivery |
| JP7077030B2 (ja) * | 2018-01-29 | 2022-05-30 | 三菱鉛筆株式会社 | 筆記具用水性インク組成物 |
| CN108605933B (zh) * | 2018-04-20 | 2021-06-15 | 上海康归生物科技有限公司 | 一种脂肪酸复合物 |
| KR102529645B1 (ko) * | 2019-12-26 | 2023-05-08 | 고려대학교 산학협력단 | 리놀레산을 포함하는 생물막 형성 억제용 조성물 및 이를 이용한 생물막 형성 억제 방법 |
| CN121668105A (zh) * | 2020-01-21 | 2026-03-17 | 勃林格殷格翰动物保健有限公司 | 用于递送功能性成分的膨胀泡沫 |
| US11298379B2 (en) * | 2020-04-16 | 2022-04-12 | James F. Kane | Compositions comprising milk fat globules and methods of making same |
| WO2022066766A1 (en) * | 2020-09-23 | 2022-03-31 | Sidharth Sareen | Anti-microbial agent |
| KR102566917B1 (ko) * | 2021-03-16 | 2023-08-14 | 영남대학교 산학협력단 | 쏘팔메토 오일 및 이의 불포화 지방산을 유효성분으로 함유하는 다중 병원성 미생물 바이오필름 형성 억제용 조성물 |
| KR102659787B1 (ko) * | 2022-01-11 | 2024-04-23 | 국민대학교산학협력단 | 베헨산을 포함하는 바이오필름 형성 억제용 조성물 |
| CN120053661A (zh) * | 2022-05-06 | 2025-05-30 | 太阳雨林(北京)生物医药有限公司 | 预防、阻止或治疗微生物感染的亲水性脂肪酸类复合物及其制备和应用 |
| KR102886232B1 (ko) | 2022-10-31 | 2025-11-13 | 전종열 | 화장품, 생활용품 및 손 세정제용 항균 조성물 |
| WO2024201283A1 (en) | 2023-03-30 | 2024-10-03 | Michael Anthony Folan | Insecticidal and arachnidicidal compositions and uses thereof |
| WO2026033433A1 (en) * | 2024-08-08 | 2026-02-12 | Unifarco S.P.A. | Composition for topical use as an adjuvant in the prevention and treatment of seborrhoeic dermatitis |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2864707A (en) * | 1956-01-16 | 1958-12-16 | Union Carbide Corp | Beverage concentrates and syrups |
| FR2324354A1 (fr) * | 1974-07-25 | 1977-04-15 | Equip Automobile Ste Fse | Composition pour la mise en emulsion aqueuse biodegradable des hydrocarbures et graisses et son procede de preparation |
| US4164594A (en) * | 1977-05-25 | 1979-08-14 | Carnation Company | Lecithin based wetting agent |
| PT710126E (pt) * | 1993-07-30 | 2004-09-30 | Aruba Internat Pty Ltd | Sistema de deslipidacao do plasma |
| US5543523A (en) * | 1994-11-15 | 1996-08-06 | Regents Of The University Of Minnesota | Method and intermediates for the synthesis of korupensamines |
| WO1997016517A1 (en) * | 1995-10-30 | 1997-05-09 | The Procter & Gamble Company | Thickened, highly aqueous, cost effective liquid detergent compositions |
| US5660858A (en) * | 1996-04-03 | 1997-08-26 | Research Triangle Pharmaceuticals | Cyclosporin emulsions |
| US6281175B1 (en) * | 1997-09-23 | 2001-08-28 | Scimed Life Systems, Inc. | Medical emulsion for lubrication and delivery of drugs |
| GB0114014D0 (en) * | 2001-06-08 | 2001-08-01 | Novartis Nutrition Ag | Compostion and use |
| CN1827766B (zh) * | 2001-06-28 | 2010-08-25 | 徐荣祥 | 体外细胞的培养方法 |
| KR100907959B1 (ko) * | 2001-08-23 | 2009-07-16 | 웨스트게이트 바이올로지컬 리미티드 | 미생물 또는 바이러스 감염의 예방 또는 치료에 있어서유청 아포단백질의 용도 |
| WO2005117600A1 (en) * | 2004-06-03 | 2005-12-15 | Pacifica Resources Sdn.Bhd. | A food surfactant |
| US20080069785A1 (en) | 2004-12-14 | 2008-03-20 | Jones Allen L | Pest-control compositions, and methods and products utilizing same |
| US7749529B2 (en) * | 2005-02-08 | 2010-07-06 | Ash Access Technology, Inc. | Catheter lock solution comprising citrate and a paraben |
| ES2345840T3 (es) | 2006-10-13 | 2010-10-04 | Evonik Goldschmidt Gmbh | Composicion para tratamiento de la piel. |
| EP2229163A1 (en) * | 2007-12-04 | 2010-09-22 | Westgate Biological Limited | Antimicrobial compositions comprising fatty acids and milk proteins |
| WO2010088645A2 (en) | 2009-02-02 | 2010-08-05 | Ecoblend, Llc | Pesticidal compositions and methods of use thereof |
| PL2501375T3 (pl) | 2009-11-17 | 2017-12-29 | Folan | Kompozycje przeciwdrobnoustrojowe zawierające wolne kwasy tłuszczowe |
| CN121668105A (zh) | 2020-01-21 | 2026-03-17 | 勃林格殷格翰动物保健有限公司 | 用于递送功能性成分的膨胀泡沫 |
| WO2024201283A1 (en) | 2023-03-30 | 2024-10-03 | Michael Anthony Folan | Insecticidal and arachnidicidal compositions and uses thereof |
-
2010
- 2010-11-17 PL PL10779550T patent/PL2501375T3/pl unknown
- 2010-11-17 CA CA2781550A patent/CA2781550C/en active Active
- 2010-11-17 CN CN201080054895.7A patent/CN102639129B/zh active Active
- 2010-11-17 US US13/510,361 patent/US20120289591A1/en not_active Abandoned
- 2010-11-17 WO PCT/EP2010/067710 patent/WO2011061237A1/en not_active Ceased
- 2010-11-17 EP EP10779550.2A patent/EP2501375B1/en active Active
- 2010-11-17 CN CN201610620706.7A patent/CN106236708B/zh active Active
- 2010-11-17 ES ES10779550.2T patent/ES2643862T3/es active Active
-
2015
- 2015-02-17 US US14/623,850 patent/US9555116B2/en active Active
-
2016
- 2016-12-20 US US15/384,372 patent/US11213503B2/en active Active
-
2021
- 2021-11-29 US US17/536,209 patent/US12208075B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2501375A1 (en) | 2012-09-26 |
| US12208075B2 (en) | 2025-01-28 |
| US11213503B2 (en) | 2022-01-04 |
| CN106236708A (zh) | 2016-12-21 |
| CN106236708B (zh) | 2020-06-26 |
| US20150157720A1 (en) | 2015-06-11 |
| CA2781550A1 (en) | 2011-05-26 |
| US20170100357A1 (en) | 2017-04-13 |
| EP2501375B1 (en) | 2017-07-19 |
| US20220151969A1 (en) | 2022-05-19 |
| ES2643862T3 (es) | 2017-11-24 |
| WO2011061237A1 (en) | 2011-05-26 |
| CA2781550C (en) | 2018-01-23 |
| US20120289591A1 (en) | 2012-11-15 |
| US9555116B2 (en) | 2017-01-31 |
| CN102639129A (zh) | 2012-08-15 |
| CN102639129B (zh) | 2016-08-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2501375T3 (pl) | Kompozycje przeciwdrobnoustrojowe zawierające wolne kwasy tłuszczowe | |
| IL251846A0 (en) | lipid preparations | |
| GB2473460B (en) | Antimicrobial Composition | |
| EP2459189A4 (en) | FATTY ACIDS AS ANTI-INFLAMMATORY AGENTS | |
| ZA201109176B (en) | Homeglobin compositions | |
| IL217949A0 (en) | Pesticdal compositions | |
| EP2483233A4 (en) | HETEROATOMA CONTAINING SUBSTITUTED FATTY ACIDS | |
| GB0906515D0 (en) | Fungical compositions | |
| GB0910046D0 (en) | Novel compositions | |
| ZA201109312B (en) | Compositions | |
| ZA201202526B (en) | Carrageenan-containing aqueous antimicrobial compositions | |
| IL214887A0 (en) | Fatty acid monoglyceride compositions | |
| GB201017722D0 (en) | Edible Composition | |
| GB0910045D0 (en) | Novel compositions | |
| GB2472315B (en) | Antibacterial compositions | |
| GB0915265D0 (en) | Confectionery composition | |
| IL219958A0 (en) | Omega-3 fatty acid enriched meat compositions | |
| IL216853A0 (en) | Agricultural compositions | |
| IL214207A0 (en) | Agricultural compositions | |
| EP2373178A4 (en) | FOOD COMPOSITIONS OF FRITTED PIECES | |
| GB0905165D0 (en) | Compositions | |
| GB0904300D0 (en) | Essential fatty acid compounds | |
| IL216681A0 (en) | Phenol ester as perfuming ingredient | |
| GB0908963D0 (en) | Compositions | |
| GB0911608D0 (en) | Sanitising compositions |